Chemotherapy for Advanced Small Bowel Cancer
Author Information
Author(s): Koo Dong Hoe, Yun Sung-Cheol, Hong Yong Sang, Ryu Min-Hee, Lee Jae-Lyun, Chang Heung-Moon, Ryoo Baek-Yeol, Kang Yoon-Koo, Kim Tae Won
Primary Institution: Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Hypothesis
Does palliative chemotherapy improve overall survival in patients with advanced small bowel adenocarcinoma?
Conclusion
Palliative chemotherapy may improve survival outcomes in patients with advanced small bowel adenocarcinoma.
Supporting Evidence
- Patients receiving chemotherapy had a median overall survival of 11.8 months.
- Patients not receiving chemotherapy had a median overall survival of 4.1 months.
- The absence of chemotherapy was associated with a significantly higher risk of mortality.
Takeaway
This study found that giving chemotherapy to patients with advanced small bowel cancer can help them live longer compared to those who don't get chemotherapy.
Methodology
Retrospective analysis of 91 patients diagnosed with advanced small bowel adenocarcinoma, comparing those who received palliative chemotherapy to those who did not.
Potential Biases
Potential selection bias due to non-randomized treatment assignment.
Limitations
The study's retrospective design and single-institution data may introduce selection biases.
Participant Demographics
Median age of participants was 58 years, with a range from 25 to 82 years.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI 2.03 - 5.83
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website